Metabolomics uncovers the diabetes metabolic network: from pathophysiological mechanisms to clinical applications

Diabetes mellitus (DM) represents a complex metabolic disorder posing urgent diagnostic and therapeutic challenges worldwide. Traditional biomarkers such as HbA1c and OGTT fail to capture the dynamic nature of metabolic remodeling underlying DM pathophysiology. Metabolomics, by offering real-time, s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Xu, Zijie (VerfasserIn) , Zhou, Yujia (VerfasserIn) , Xie, Ruijie (VerfasserIn) , Ning, Zhongxing (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 04 September 2025
In: Frontiers in endocrinology
Year: 2025, Jahrgang: 16, Pages: 1-17
ISSN:1664-2392
DOI:10.3389/fendo.2025.1624878
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fendo.2025.1624878
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1624878/full
Volltext
Verfasserangaben:Zijie Xu, Yujia Zhou, Ruijie Xie and Zhongxing Ning

MARC

LEADER 00000naa a2200000 c 4500
001 1960504487
003 DE-627
005 20260210125856.0
007 cr uuu---uuuuu
008 260210s2025 xx |||||o 00| ||eng c
024 7 |a 10.3389/fendo.2025.1624878  |2 doi 
035 |a (DE-627)1960504487 
035 |a (DE-599)KXP1960504487 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Xu, Zijie  |e VerfasserIn  |0 (DE-588)1389412547  |0 (DE-627)1960507087  |4 aut 
245 1 0 |a Metabolomics uncovers the diabetes metabolic network  |b from pathophysiological mechanisms to clinical applications  |c Zijie Xu, Yujia Zhou, Ruijie Xie and Zhongxing Ning 
264 1 |c 04 September 2025 
300 |b Illustrationen 
300 |a 17 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.02.2026 
520 |a Diabetes mellitus (DM) represents a complex metabolic disorder posing urgent diagnostic and therapeutic challenges worldwide. Traditional biomarkers such as HbA1c and OGTT fail to capture the dynamic nature of metabolic remodeling underlying DM pathophysiology. Metabolomics, by offering real-time, systems-level insights into small-molecule dynamics, has emerged as a promising strategy for both early disease detection and therapeutic target discovery. Recent studies have highlighted the diagnostic and prognostic value of metabolites, including branched-chain amino acids, lipid derivatives, and bile acids. Despite its immense potential, the clinical application of metabolomics remains hindered by technical limitations, such as cross-cohort standardization and data interpretation complexity. Future advances integrating artificial intelligence and multi-omics strategies may transform metabolomics from an exploratory tool to a clinical mainstay in diabetes management. This review offers a comprehensive synthesis of recent advances in metabolomics-driven diabetes research, with a particular focus on elucidating key metabolic pathways, identifying emerging biomarkers, and exploring translational opportunities. To fully realize the clinical potential of metabolomics, further efforts toward analytical standardization, cross-cohort validation, and the integration of artificial intelligence-powered tools will be essential to bridge the gap from bench to bedside in diabetes care. 
650 4 |a biomarkers 
650 4 |a clinical translation 
650 4 |a diabetes mellitus 
650 4 |a metabolic reprogramming 
650 4 |a metabolomics 
650 4 |a precision medicine 
700 1 |a Zhou, Yujia  |e VerfasserIn  |4 aut 
700 1 |a Xie, Ruijie  |e VerfasserIn  |0 (DE-588)1309114528  |0 (DE-627)1869712021  |4 aut 
700 1 |a Ning, Zhongxing  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in endocrinology  |d Lausanne : Frontiers Research Foundation, 2010  |g 16(2025), Artikel-ID 1624878, Seite 1-17  |h Online-Ressource  |w (DE-627)645090948  |w (DE-600)2592084-4  |w (DE-576)336962975  |x 1664-2392  |7 nnas  |a Metabolomics uncovers the diabetes metabolic network from pathophysiological mechanisms to clinical applications 
773 1 8 |g volume:16  |g year:2025  |g elocationid:1624878  |g pages:1-17  |g extent:17  |a Metabolomics uncovers the diabetes metabolic network from pathophysiological mechanisms to clinical applications 
856 4 0 |u https://doi.org/10.3389/fendo.2025.1624878  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1624878/full  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20260210 
993 |a Article 
994 |a 2025 
998 |g 1309114528  |a Xie, Ruijie  |m 1309114528:Xie, Ruijie  |d 50000  |e 50000PX1309114528  |k 0/50000/  |p 3 
999 |a KXP-PPN1960504487  |e 4912320757 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.3389/fendo.2025.1624878"],"eki":["1960504487"]},"name":{"displayForm":["Zijie Xu, Yujia Zhou, Ruijie Xie and Zhongxing Ning"]},"physDesc":[{"noteIll":"Illustrationen","extent":"17 S."}],"recId":"1960504487","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 10.02.2026"],"title":[{"subtitle":"from pathophysiological mechanisms to clinical applications","title":"Metabolomics uncovers the diabetes metabolic network","title_sort":"Metabolomics uncovers the diabetes metabolic network"}],"origin":[{"dateIssuedDisp":"04 September 2025","dateIssuedKey":"2025"}],"person":[{"display":"Xu, Zijie","family":"Xu","role":"aut","given":"Zijie"},{"family":"Zhou","given":"Yujia","role":"aut","display":"Zhou, Yujia"},{"family":"Xie","role":"aut","given":"Ruijie","display":"Xie, Ruijie"},{"given":"Zhongxing","role":"aut","family":"Ning","display":"Ning, Zhongxing"}],"relHost":[{"titleAlt":[{"title":"Bone Research"},{"title":"Cancer Endocrinology"},{"title":"Cellular Endocrinology"},{"title":"Diabetes"},{"title":"Endocrinology of Aging"},{"title":"Experimental Endocrinology"},{"title":"Genomic Endocrinology"},{"title":"Molecular and Structural Endocrinology"},{"title":"Neuroendocrine Science"},{"title":"Pediatric Endocrinology"},{"title":"Pituitary Endocrinology"},{"title":"Systems and Translational Endocrinology"},{"title":"Thyroid Endocrinology"}],"pubHistory":["1.2010 -"],"part":{"volume":"16","text":"16(2025), Artikel-ID 1624878, Seite 1-17","extent":"17","pages":"1-17","year":"2025"},"id":{"zdb":["2592084-4"],"issn":["1664-2392"],"eki":["645090948"]},"origin":[{"publisher":"Frontiers Research Foundation","dateIssuedKey":"2010","dateIssuedDisp":"2010-","publisherPlace":"Lausanne"}],"title":[{"title":"Frontiers in endocrinology","title_sort":"Frontiers in endocrinology"}],"note":["Gesehen am 12.12.19","Specialty sections: Bone Research; Cancer Endocrinology; Cellular Endocrinology; Diabetes; Endocrinology of Aging; Experimental Endocrinology; Genomic Endocrinology; Molecular and Structural Endocrinology; Neuroendocrine Science; Pediatric Endocrinology; Pituitary Endocrinology; Systems and Translational Endocrinology; Thyroid Endocrinology"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"recId":"645090948","physDesc":[{"extent":"Online-Ressource"}],"disp":"Metabolomics uncovers the diabetes metabolic network from pathophysiological mechanisms to clinical applicationsFrontiers in endocrinology"}]} 
SRT |a XUZIJIEZHOMETABOLOMI0420